http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1615884-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dee3727dba91e4e7aa3b26ce9efbcc21
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
filingDate 2004-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbae88aad51a70e95d019c5f663ddde1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f5dfaa5b7117e0065fa086e5c4b2125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ea058a0d55089035ad9096e5161f842
publicationDate 2006-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1615884-A1
titleOfInvention Process for the preparation of amorphous calcium salt of atorvastatin
abstract Present invention refers to the process of preparing amorphous atorvastatin calcium without intermediate isolation of crystal or undefined mixture of crystal and amorphous atorvastatin calcium, respectively. Forming of calcium atorvastatin salt is carried out in a mixture of chlorinated organic solvent or cyclic hydrocarbon solvent, respectively, the non-hydroxylic organic solvent, and water, the source of calcium ions is calcium acetate or calcium chloride, respectively.
priorityDate 2003-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68440875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228984276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226672572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129396299
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6278
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12418
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129190840
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394982
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9851656
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60822
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7406
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394983
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395936
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66658574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129080865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129742546

Total number of triples: 42.